サマリー

オートインジェクターの世界市場 2023-2027
Technavioは、自動注射器市場をモニターしており、2022年から2027年の間に1億3401万5800ドル、予測期間中のCAGRは25.14%で加速して成長すると予測しています。当レポートでは、自動注射器市場について、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、アレルギーの有病率の増加と即時治療の必要性、注射療法の人気の高まり、新製品の商業認可の増加によって牽引されています。
Technavioの自動注射器市場は以下のようにセグメント化されています：
用途別
- アナフィラキシー
- 多発性硬化症
- 関節リュウマチ
- 糖尿病
エンドユーザー別
- 病院・診療所
- セルフアドミニストレーション
地理的景観別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、企業間の戦略的提携が、今後数年間の自己注射器市場の成長を促進する主要な理由の1つであることを明らかにしています。また、新製品発売の増加や革新的なアナフィラキシー自動注射器の認知度向上は、市場の大きな需要につながるでしょう。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。自動注射器市場に関する弊社のレポートは、以下の分野をカバーしています：
- 自動注射器の市場サイジング
- オートインジェクター市場予測
- 自動注射器市場の産業分析
Technavioの強固なベンダー分析は、顧客が市場での地位を向上させることを目的としており、これに沿って、本レポートでは、AbbVie Inc.、Amgen Inc.、Bayer AG、Becton Dickinson and Co.、Eli Lilly and Co.を含む複数の自動注射器市場の主要ベンダーについて詳細に分析します、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Halozyme Therapeutics Inc.、Johnson and Johnson Services Inc.、Johnson Medtech LLC、medmix Ltd. 、Merck KGaA、 Owen Mumford Ltd. 、Pfizer Inc. RAVIMED Sp. zoo、 Recipharm AB、SHL Medical AG、Teva Pharmaceutical Industries Ltd. 、Viatris Inc. およびYpsomed AGがあります。また、自動注射器市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/autoinjectors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global autoinjectors market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Anaphylaxis - Market size and forecast 2022-2027
o Exhibit 34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
o 6.4 Multiple sclerosis - Market size and forecast 2022-2027
o Exhibit 38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
o 6.5 Rheumatoid arthritis - Market size and forecast 2022-2027
o Exhibit 42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
o 6.6 Diabetes - Market size and forecast 2022-2027
o Exhibit 46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ million)
o Exhibit 51: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Hospitals and clinics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o 7.4 Self-administration - Market size and forecast 2022-2027
o Exhibit 60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 119: Amgen Inc. - Overview
o Exhibit 120: Amgen Inc. - Product / Service
o Exhibit 121: Amgen Inc. - Key offerings
o 12.5 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key news
o Exhibit 125: Bayer AG - Key offerings
o Exhibit 126: Bayer AG - Segment focus
o 12.6 Becton Dickinson and Co.
o Exhibit 127: Becton Dickinson and Co. - Overview
o Exhibit 128: Becton Dickinson and Co. - Business segments
o Exhibit 129: Becton Dickinson and Co. - Key news
o Exhibit 130: Becton Dickinson and Co. - Key offerings
o Exhibit 131: Becton Dickinson and Co. - Segment focus
o 12.7 Eli Lilly and Co.
o Exhibit 132: Eli Lilly and Co. - Overview
o Exhibit 133: Eli Lilly and Co. - Product / Service
o Exhibit 134: Eli Lilly and Co. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 140: GlaxoSmithKline Plc - Overview
o Exhibit 141: GlaxoSmithKline Plc - Business segments
o Exhibit 142: GlaxoSmithKline Plc - Key news
o Exhibit 143: GlaxoSmithKline Plc - Key offerings
o Exhibit 144: GlaxoSmithKline Plc - Segment focus
o 12.10 Halozyme Therapeutics Inc.
o Exhibit 145: Halozyme Therapeutics Inc. - Overview
o Exhibit 146: Halozyme Therapeutics Inc. - Product / Service
o Exhibit 147: Halozyme Therapeutics Inc. - Key offerings
o 12.11 Merck KGaA
o Exhibit 148: Merck KGaA - Overview
o Exhibit 149: Merck KGaA - Business segments
o Exhibit 150: Merck KGaA - Key news
o Exhibit 151: Merck KGaA - Key offerings
o Exhibit 152: Merck KGaA - Segment focus
o 12.12 Owen Mumford Ltd.
o Exhibit 153: Owen Mumford Ltd. - Overview
o Exhibit 154: Owen Mumford Ltd. - Product / Service
o Exhibit 155: Owen Mumford Ltd. - Key offerings
o 12.13 Pfizer Inc.
o Exhibit 156: Pfizer Inc. - Overview
o Exhibit 157: Pfizer Inc. - Product / Service
o Exhibit 158: Pfizer Inc. - Key news
o Exhibit 159: Pfizer Inc. - Key offerings
o 12.14 Recipharm AB
o Exhibit 160: Recipharm AB - Overview
o Exhibit 161: Recipharm AB - Business segments
o Exhibit 162: Recipharm AB - Key offerings
o Exhibit 163: Recipharm AB - Segment focus
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.16 Viatris Inc.
o Exhibit 169: Viatris Inc. - Overview
o Exhibit 170: Viatris Inc. - Business segments
o Exhibit 171: Viatris Inc. - Key offerings
o Exhibit 172: Viatris Inc. - Segment focus
o 12.17 Ypsomed AG
o Exhibit 173: Ypsomed AG - Overview
o Exhibit 174: Ypsomed AG - Business segments
o Exhibit 175: Ypsomed AG - Key offerings
o Exhibit 176: Ypsomed AG - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global autoinjectors market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Anaphylaxis - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Anaphylaxis - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Anaphylaxis - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Multiple sclerosis - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Multiple sclerosis - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Rheumatoid arthritis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Rheumatoid arthritis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Diabetes - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Diabetes - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Diabetes - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Diabetes - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ million)
Exhibits51: Data Table on Market opportunity by Application ($ million)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Self-administration - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Self-administration - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Self-administration - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Self-administration - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Amgen Inc. - Overview
Exhibits120: Amgen Inc. - Product / Service
Exhibits121: Amgen Inc. - Key offerings
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key news
Exhibits125: Bayer AG - Key offerings
Exhibits126: Bayer AG - Segment focus
Exhibits127: Becton Dickinson and Co. - Overview
Exhibits128: Becton Dickinson and Co. - Business segments
Exhibits129: Becton Dickinson and Co. - Key news
Exhibits130: Becton Dickinson and Co. - Key offerings
Exhibits131: Becton Dickinson and Co. - Segment focus
Exhibits132: Eli Lilly and Co. - Overview
Exhibits133: Eli Lilly and Co. - Product / Service
Exhibits134: Eli Lilly and Co. - Key offerings
Exhibits135: F. Hoffmann La Roche Ltd. - Overview
Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits137: F. Hoffmann La Roche Ltd. - Key news
Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits140: GlaxoSmithKline Plc - Overview
Exhibits141: GlaxoSmithKline Plc - Business segments
Exhibits142: GlaxoSmithKline Plc - Key news
Exhibits143: GlaxoSmithKline Plc - Key offerings
Exhibits144: GlaxoSmithKline Plc - Segment focus
Exhibits145: Halozyme Therapeutics Inc. - Overview
Exhibits146: Halozyme Therapeutics Inc. - Product / Service
Exhibits147: Halozyme Therapeutics Inc. - Key offerings
Exhibits148: Merck KGaA - Overview
Exhibits149: Merck KGaA - Business segments
Exhibits150: Merck KGaA - Key news
Exhibits151: Merck KGaA - Key offerings
Exhibits152: Merck KGaA - Segment focus
Exhibits153: Owen Mumford Ltd. - Overview
Exhibits154: Owen Mumford Ltd. - Product / Service
Exhibits155: Owen Mumford Ltd. - Key offerings
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Recipharm AB - Overview
Exhibits161: Recipharm AB - Business segments
Exhibits162: Recipharm AB - Key offerings
Exhibits163: Recipharm AB - Segment focus
Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits169: Viatris Inc. - Overview
Exhibits170: Viatris Inc. - Business segments
Exhibits171: Viatris Inc. - Key offerings
Exhibits172: Viatris Inc. - Segment focus
Exhibits173: Ypsomed AG - Overview
Exhibits174: Ypsomed AG - Business segments
Exhibits175: Ypsomed AG - Key offerings
Exhibits176: Ypsomed AG - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations